Suppr超能文献

同期胸主动脉腔内修复术和主动脉腔内修复术具有较低的发病率和死亡率,是可行的。

Simultaneous thoracic endovascular aortic repair and endovascular aortic repair is feasible with minimal morbidity and mortality.

机构信息

Division of Vascular Surgery and Endovascular Therapy, University of Pennsylvania Health System, Philadelphia, PA 19104, USA.

出版信息

J Vasc Surg. 2011 Dec;54(6):1588-91. doi: 10.1016/j.jvs.2011.05.112. Epub 2011 Sep 9.

Abstract

OBJECTIVE

To determine the results of simultaneous thoracic endovascular aortic repair (TEVAR) and endovascular aneurysm repair (EVAR).

METHODS

Records were retrospectively reviewed. Eight patients underwent simultaneous TEVAR and EVAR between 1999 and 2010 at a single center. All patients had concomitant thoracic and abdominal aortic disease (aneurysms, penetrating aortic ulcers). Ranges for the thoracic and abdominal aneurysm diameters were 6.0 to 9.1 cm and 5.0 to 7.6 cm, respectively. Four patients were treated emergently, and the remainder had indications for simultaneous repair. The mean age was 72 years (six males). All patients had significant comorbidities.

RESULTS

Average procedural time was 173 minutes ± 25 minutes. Spinal drainage and neuromonitoring was used in all cases. Thoracic endovascular aortic repair (TEVAR) was performed prior to EVAR. Three patients required left subclavian coverage and four patients had full coverage of the thoracic aorta. Only one patient had internal iliac artery (unilateral) coverage. One patient was lost to follow-up 6 weeks following discharge. The remainder were followed between 4 and 77 months postoperatively. No patients developed acute myocardial infarction, acute renal failure, or neurologic complications, including permanent paralysis or stroke. One patient developed transient lower extremity weakness that resolved with blood pressure augmentation. Mean blood loss was 325 mL ± 137 mL. The average intensive care unit and hospital stay was 3 days and 8 days, respectively. In follow-up, one patient developed a type II endoleak that was successfully embolized.

CONCLUSION

Combined TEVAR and EVAR can be performed successfully with minimal morbidity and mortality. In particular, in this limited series of eight patients, there have been no occurrences of lower extremity paralysis or renal failure despite a high proportion of emergent cases. When anatomically feasible, simultaneous TEVAR and EVAR can be considered as a viable alternative to staged or hybrid repair.

摘要

目的

确定同期胸主动脉腔内修复术(TEVAR)和血管内动脉瘤修复术(EVAR)的结果。

方法

回顾性分析记录。1999 年至 2010 年间,在一家中心有 8 例患者接受了同期 TEVAR 和 EVAR。所有患者均患有胸腹部主动脉疾病(动脉瘤、穿透性主动脉溃疡)。胸主动脉瘤和腹主动脉瘤的直径范围分别为 6.0 至 9.1 厘米和 5.0 至 7.6 厘米。4 例患者为急诊治疗,其余患者有同时修复的适应证。平均年龄为 72 岁(6 例男性)。所有患者均有明显的合并症。

结果

平均手术时间为 173 分钟±25 分钟。所有病例均使用脊柱引流和神经监测。TEVAR 在前,EVAR 在后。3 例患者需要左锁骨下动脉覆盖,4 例患者胸主动脉完全覆盖。仅 1 例患者行单侧髂内动脉覆盖。1 例患者在出院后 6 周失访。其余患者术后随访 4 至 77 个月。无患者发生急性心肌梗死、急性肾衰竭或神经系统并发症,包括永久性瘫痪或中风。1 例患者出现短暂性下肢无力,血压升高后缓解。平均失血量为 325 毫升±137 毫升。平均重症监护病房和住院时间分别为 3 天和 8 天。在随访中,1 例患者出现 II 型内漏,成功栓塞。

结论

同期 TEVAR 和 EVAR 可成功实施,发病率和死亡率低。特别是在这 8 例患者的有限系列中,尽管急诊患者比例较高,但无下肢瘫痪或肾衰竭发生。在解剖学可行的情况下,同期 TEVAR 和 EVAR 可作为分期或杂交修复的可行替代方案。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验